Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Renal Failure

Free Subscription 03.11.2025 2 Clin J Am Soc Nephrol 1 Curr Opin Nephrol Hypertens 1 J Am Soc Nephrol 7 J Nephrol 3 J Ren Nutr 4 N Engl J Med 6 Nephrol Dial Transplant 1 Nephron 1 Osteoporos Int 3 PLoS One 3 Ren Fail 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin J Am Soc Nephrol

1. MARTINEZ-AMEZCUA P, Fuentes-Mercado A, Etzkorn LH, Schrack JA, et al
   Differences in Physical Activity Assessed by Accelerometry Across Hemodialysis Days and Shifts.
   Clin J Am Soc Nephrol. 2025 Oct 27. doi: 10.2215/CJN.0000000914.
   PubMed        
   
   
2. BANSAL N, Rivara M, Sarathy H, Clark C, et al
   A Qualitative Study of Nephrologists' Perceptions of Management of Hypertension in Hemodialysis Patients.
   Clin J Am Soc Nephrol. 2025 Oct 27. doi: 10.2215/CJN.0000000885.
   PubMed        
   
   

   
   Curr Opin Nephrol Hypertens

3. BANSAL S, Nararyan R
   Management of peritoneal dialysis in patients with obesity.
   Curr Opin Nephrol Hypertens. 2025 Oct 24. doi: 10.1097/MNH.0000000000001124.
   PubMed         Abstract available
   
   

   
   J Am Soc Nephrol

4. MAYNE KJ, Herrington WG
   "Hi"s and "Lo"s of Targeting Serum Phosphate Levels in Hemodialysis.
   J Am Soc Nephrol. 2025 Oct 30. doi: 10.1681/ASN.0000000903.
   PubMed        
   
   

   
   J Nephrol

5. KANAKUBO Y, Inanaga R, Toida T, Aita T, et al
   Correction: Trust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: a cross-sectional study.
   J Nephrol. 2025 Oct 29. doi: 10.1007/s40620-025-02457.
   PubMed        
   
   
6. ITO S, Matsumoto M, Shimono A, Teranishi H, et al
   Characteristics and clinical courses of patients with atypical haemolytic uraemic syndrome on dialysis withdrawal after eculizumab treatment: sub-analysis of post-marketing surveillance in Japan.
   J Nephrol. 2025 Oct 28. doi: 10.1007/s40620-025-02433.
   PubMed         Abstract available
   
   
7. QIAO Y, Gao S, Li S, Pei H, et al
   The association between empirical antibiotic regimens and the outcome of peritoneal dialysis-related peritonitis: a multi-center, large-scale cohort study.
   J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02437.
   PubMed         Abstract available
   
   
8. CHOQUET Q, Novel-Catin E, Laubacher M, Massat M, et al
   Contrast-induced encephalopathy after cerebral aneurysm embolization in a chronic hemodialysis patient: a case-report.
   J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02374.
   PubMed        
   
   
9. PAGES H, Kosmadakis G, Kanouni FE, Necoara A, et al
   Evaluation of multidisciplinary care pathways on kidney function in patients with advanced chronic kidney disease: multicenter study.
   J Nephrol. 2025 Oct 27. doi: 10.1007/s40620-025-02365.
   PubMed         Abstract available
   
   
10. ELKERAIE A, Elraggal M, AbouKhatwa M, Omar ME, et al
    Safety of SGLT2 inhibitors in chronic kidney disease patients during Ramadan fasting: a prospective cohort study.
    J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02438.
    PubMed         Abstract available
    
    
11. CHUANG GT, Hsiung CN, Che TP, Oh KH, et al
    Correction: Genome-wide polygenic risk score for estimated glomerular filtration slope predicts chronic kidney disease in a Taiwanese population.
    J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02456.
    PubMed        
    
    

    
    J Ren Nutr

12. BAL AZ, Turgay G, Tekinyildiz M, Sezer S, et al
    Decreased Olfactory Function is associated with Mortality in Hemodialysis Patients.
    J Ren Nutr. 2025 Oct 23:S1051-2276(25)00221-3. doi: 10.1053/j.jrn.2025.
    PubMed         Abstract available
    
    
13. HAMDAN H, Kim TY, Plantinga LC, Seligman H, et al
    Diet Quality, Food Insecurity and Chronic Kidney Disease: Insights from the U.S. National Health and Nutrition Examination Survey.
    J Ren Nutr. 2025 Oct 23:S1051-2276(25)00222-5. doi: 10.1053/j.jrn.2025.
    PubMed         Abstract available
    
    
14. MOHAMMADI MA, Behrouz V, Shahabi A, Abbas-Hashemi SA, et al
    The association between dietary inflammatory index and risk of chronic kidney disease: an updated systematic review and dose-response meta-analysis of observational studies.
    J Ren Nutr. 2025 Oct 23:S1051-2276(25)00223-7. doi: 10.1053/j.jrn.2025.
    PubMed         Abstract available
    
    

    
    N Engl J Med

15. ASSIL R, Hough A
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1753-1754.
    PubMed        
    
    
16. SILVER S
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1754.
    PubMed        
    
    
17. ROMAGNANI P, Soler MJ, Fervenza FC
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1754.
    PubMed        
    
    
18. AGARWAL R, Rossing P, Mann JFE
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. Reply.
    N Engl J Med. 2025;393:1755.
    PubMed        
    
    

    
    Nephrol Dial Transplant

19. HEERSPINK HJL, van Raalte DH, Bjornstad P, Bunck MC, et al
    Rationale, Design, and Baseline Characteristics of the TRANSCEND-CKD trial of Retatrutide in Patients with Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Oct 29:gfaf230. doi: 10.1093.
    PubMed         Abstract available
    
    
20. MORALES E, Jenssen TG, Bevc S, Miglinas M, et al
    Obesity as a modifiable risk factor in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Oct 30:gfaf231. doi: 10.1093.
    PubMed         Abstract available
    
    
21. VIRAMONTES-HORNER D, Stewart P, Stewart J, Taal MW, et al
    A novel system to continuously estimate intradialytic blood pressure in real time.
    Nephrol Dial Transplant. 2025;40:2074-2080.
    PubMed         Abstract available
    
    
22. HAUPENTHAL F, Doberer K, Kapps S, Klager J, et al
    Self-reported Non-adherence to Immunosuppressive Medication Detected by the BAASIS Predicts Allograft Rejections in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 28:gfaf078. doi: 10.1093.
    PubMed         Abstract available
    
    
23. SIM JJ, Chen Q, Cannizzaro N, Fernandes AW, et al
    CKD progression, kidney failure, and mortality among US patients with IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:2104-2117.
    PubMed         Abstract available
    
    
24. SATISH P, Smith R, Alasadi A, Frackiewicz E, et al
    A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality.
    Nephrol Dial Transplant. 2025;40:2159-2168.
    PubMed         Abstract available
    
    

    
    Nephron

25. CETIN GUVENC R, Guvenc TS, Karakaya ES, Acik H, et al
    Abnormal Right Ventricular to Pulmonary Artery Coupling in Patients with End-Stage Kidney Disease and Normalization After Renal Transplantation: An Observational Study.
    Nephron. 2025 Oct 30:1-18. doi: 10.1159/000549077.
    PubMed         Abstract available
    
    

    
    Osteoporos Int

26. ABDALBARY M, Amin AM, Elaraby A, Hassan A, et al
    Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review.
    Osteoporos Int. 2025 Oct 31. doi: 10.1007/s00198-025-07707.
    PubMed         Abstract available
    
    

    
    PLoS One

27. DIAZ-OBREGON DZ, Goyoneche Linares G, Granda Alacote A, Murillo Carrasco AG, et al
    Variability of the lymphocyte-to-monocyte ratio in patients with chronic kidney disease on hemodialysis.
    PLoS One. 2025;20:e0333523.
    PubMed         Abstract available
    
    
28. ANOKYE R, Larkin J, Fehintola A, Eustace-Cook J, et al
    Understanding the social dimensions of kidney care pathways: A scoping review protocol.
    PLoS One. 2025;20:e0335597.
    PubMed         Abstract available
    
    
29. JIANG Y, Cui C, Nan H, Chang T, et al
    Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients.
    PLoS One. 2025;20:e0335599.
    PubMed         Abstract available
    
    

    
    Ren Fail

30. ZHANG Y, Yuan R, Li D
    Association between triglyceride-glucose index and risk of chronic kidney disease: a meta-analysis.
    Ren Fail. 2025;47:2572356.
    PubMed         Abstract available
    
    
31. YE Y, Liu S, Shao S, Gu Y, et al
    Association between sensitivity to thyroid hormone indices and chronic kidney disease in US adults from NHANES 2007-2012.
    Ren Fail. 2025;47:2575436.
    PubMed         Abstract available
    
    
32. FAN Z, Feng C, Li X, Zhang Z, et al
    Association between uric acid to high-density lipoprotein cholesterol ratio and chronic kidney disease in middle-aged and older adults: results from two nationally representative population-based study.
    Ren Fail. 2025;47:2575920.
    PubMed         Abstract available
    
    

    
    Transplantation

33. LIN L, Chen T, Yu S, Chen H, et al
    Normothermic Machine Perfusion Combined With Modified Small Interfering RNA Targeting Beta-2-microglobulin and Class II Major Histocompatibility Complex Transactivator Mitigates Acute Rejection of Renal Allograft.
    Transplantation. 2025 Oct 28. doi: 10.1097/TP.0000000000005529.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.